FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

736536005: Voxilaprevir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3518061013 Voxilaprevir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3518062018 Voxilaprevir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3518061013 Voxilaprevir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3518062018 Voxilaprevir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
849821000172111 voxilaprevir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
849821000172111 voxilaprevir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Voxilaprevir (substance) Has disposition Hepatitis C virus NS3/4A protease inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Voxilaprevir (substance) Is a Hepatitis C virus NS3/4A protease inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Sofosbuvir- and velpatasvir- and voxilaprevir-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only sofosbuvir and velpatasvir and voxilaprevir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing voxilaprevir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Voxilaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3

This concept is not in any reference sets

Back to Start